[The use of streptokinase preparations in pleural empyema and pyopneumothorax].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 8202857)

Published in Ter Arkh on January 01, 1994

Authors

Ia N Shoĭkhet, O G Ogloblina, E A Tseĭmakh, T D Mal'chenko

Articles by these authors

[Use of an endobronchial valve in complex treatment of patients with infiltrative pulmonary tuberculosis]. Probl Tuberk Bolezn Legk (2008) 0.87

[The specific features of respiratory support in patients with obstructive sleep apnoea syndrome concurrent with chronic obstructive pulmonary disease (crossing-syndrome)]. Ter Arkh (2010) 0.77

[Kininogenase activity of cathepsins D]. Biokhimiia (1980) 0.77

[Specific plasma sorption of proteinases--a new approach to the treatment of acute pancreatitis]. Khirurgiia (Mosk) (1991) 0.75

[Arterial hypertension in patients with chronic obstructive pulmonary disease in combination with coronary artery disease]. Ter Arkh (2008) 0.75

[Comparative assessment of the effectiveness of auto- and homohemotransfusion in experimental hemorrhagic shock]. Eksp Khir Anesteziol (1972) 0.75

[Dynamics of changes in the protease-inhibitory balance in blood plasma of dogs with experimental acute pancreatitis]. Patol Fiziol Eksp Ter (1991) 0.75

[Inhibition of human granulocyte elastase and kininogenase]. Biokhimiia (1983) 0.75

[The enhanced activity of chymotrypsin-like proteinases in the blood plasma of patients with hereditary hypercholesterolemia and the means for its correction]. Ter Arkh (1992) 0.75

[Processes of modification of lipoproteins. Physiological and pathogenetical role of modified lipoproteins]. Vopr Med Khim (2000) 0.75

[Urogenital pathology in patients with chronic obstructive lung disease and ischemic heart disease]. Klin Med (Mosk) (2008) 0.75

[The investigation of prevalence of genital inflammation in women of second generation of descendants whose ancestors were in the area of radiation exposure]. Vestn Ross Akad Med Nauk (2012) 0.75

[Extracorporeal circulation methods in the treatment of nonspecific aortic arteritis]. Ter Arkh (1998) 0.75

[Substantiation, tactics and effectiveness of frozen plasma-enzyme inhibitor therapy in septicemia and infectious-destructive processes]. Gematol Transfuziol (1989) 0.75

[Imbalance of the plasma proteinase-inhibitory system in familial hypercholesterolemia]. Kardiologiia (1989) 0.75

[Granulocyte elastase activity and the content of acid-stable proteinase inhibitors in the oral fluid of patients with inflammatory periodontal diseases]. Stomatologiia (Mosk) (1986) 0.75

[The biochemical and clinical aspects of the participation of granulocytes and their proteinases in a vascular wall lesion]. Ter Arkh (1996) 0.75

[Relationship of effective treatment of inflammatory destructive diseases with microcirculatory deblockage in the diseased organs]. Vestn Ross Akad Med Nauk (2000) 0.75

[Obstructive sleep apnea syndrome in patients with chronic obstructive pulmonary disorder]. Klin Med (Mosk) (2012) 0.75

[Peculiarities of the treatment of obstructive pulmonary disease in patients with combined pathology]. Klin Med (Mosk) (2009) 0.75

[Microcirculatory disorders in the surgical treatment of lung cancer]. Grudn Khir (1981) 0.75

[Plasminogen activator: human granulocyte "kininogenase"; inhibition by an acid-stable inhibitor from blood plasma]. Dokl Akad Nauk SSSR (1982) 0.75

[Potential clinical use of an acid-stable proteinase inhibitor from human urine]. Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR (1987) 0.75

[Evaluation of the degree of trauma in biliary tract surgery using a laser method in relation to the status of the plasma protease inhibitor system]. Sov Med (1991) 0.75

[Comparative data on the use of a cryosupernatant and fresh-frozen plasma in the therapy of a protracted infectious-septic syndrome of disseminated intravascular coagulation]. Ter Arkh (1998) 0.75

Modification of carboxyl groups in pepsin. Eur J Biochem (1973) 0.75

[Activity of granulocyte proteases and their acid-resistant inhibitors in bronchial secretions of patients with tuberculosis, complicated by nonspecific endobronchitis]. Probl Tuberk (1983) 0.75

[Autohemotransfusions in a surgical clinic]. Vestn Khir Im I I Grek (1974) 0.75

[Procoagulant and proteolytic activities of leukocytes in the foci of acute abscesses and gangrene of the lungs]. Klin Med (Mosk) (1991) 0.75

[Clinical value of determining the activity of elastase- and chymotrypsin-like proteinases in the plasma of patients with nonspecific aortoarteritis and arteriosclerosis]. Kardiologiia (1989) 0.75

[Monoclonal antibodies to the trypsin-binding domain of trypsin inhibitor from human urine]. Bioorg Khim (1994) 0.75

[Property of a heat- and acid-stable inhibitor of serine proteinases from the blood serum to inhibit lymphcyte transformation stimulated by mitogens]. Biull Eksp Biol Med (1978) 0.75

[Functional state of the kidneys after surgical treatment of acute cholecystitis]. Klin Med (Mosk) (1985) 0.75

[The Janus syndrome observed during mass fluorographic screening of the population]. Vestn Rentgenol Radiol (1991) 0.75

[The role of granulocytic proteinases and their inhibitors in the pathogenesis of nonspecific endobronchitis (review)]. Vopr Med Khim (1984) 0.75

[Effective method of isolating an acid-stable protease inhibitor from human urine]. Vopr Med Khim (1987) 0.75

[Peculiarities of thrombin generation and prognosis of unfavourable outcome in patients with severe pneumonia and pneumogenic sepsis]. Klin Med (Mosk) (2014) 0.75

[Clinical importance of determining the activity of an acid-stable proteinase inhibitor in the urine of arterial hypertension patients]. Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR (1987) 0.75

[Computer program for diagnosis, monitoring, and prophylaxis of cardiovascular diseases]. Klin Lab Diagn (2002) 0.75

[Inhibition of human granulocyte proteinases by a heat and acid-stable proteinase inhibitor from rabbit serum]. Biokhimiia (1979) 0.75

[Plasmapheresis in combined treatment of severe forms of abscesses and gangrene of the lungs]. Klin Med (Mosk) (1989) 0.75

[Circulatory disorders in the surgical treatment of lung cancer in persons with ischemic heart disease]. Grudn Khir (1981) 0.75

[Changes in hepatic blood flow in patients with chronic cholecystitis complicated by mechanical jaundice]. Khirurgiia (Mosk) (1984) 0.75

[The possibility of clinical diagnosis of non-massive pulmonary thromboembolism under conditions of limited availability of instrumental diagnostic tools]. Klin Med (Mosk) (2009) 0.75

[Concentration of acid-stable inhibitors--metabolites of plasma inter-alpha trypsin inhibitor--in the urine of healthy people and in patients with nephrotic syndrome]. Vopr Med Khim (1984) 0.75

[Local immune and inhibitor protection in patients with newly detected destructive pulmonary tuberculosis complicated by nonspecific endobronchitis]. Ter Arkh (1984) 0.75

[Correction (in vitro) of proteinase inhibitor balance in the blood of patients after cardiosurgical interventions]. Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR (1988) 0.75

[Basic functional rehabilitation of patients with squamous cell carcinoma of the mouth floor]. Vopr Onkol (2007) 0.75

[Nonspecific aortoarteritis: its clinical course and elastase-like proteinase activity of the blood plasma]. Kardiologiia (1988) 0.75

[Various aspects of phagocyte participation in the pathogenesis of pulmonary abscesses and gangrene]. Ter Arkh (1991) 0.75

[Acid-stable proteinase inhibitor from the urine of pregnant women, the properties of the highly purified preparation and the isolation of a monospecific antiserum]. Vopr Med Khim (1982) 0.75

[Elastase and acid phosphatase activity in bronchoalveolar lavage fluid during chronic bronchitis]. Biull Eksp Biol Med (1990) 0.75

[Clinical features of systemic scleroderma with lesions in respiratory organs]. Klin Med (Mosk) (2013) 0.75

[Evaluation of the effectiveness of the use of specific hemosorption in acute experimental pancreatitis]. Biull Eksp Biol Med (1988) 0.75

[Intensification of the effect of exogenous plasminogen activators on lysis of fibrin blood clots due to a decrease in the level of alpha-2- antiplasmin by a plasmasorption method]. Biokhimiia (1994) 0.75

[Identity of kininogenase and plasminogen activators in human granulocytes]. Biokhimiia (1984) 0.75

[Remote results of ultrasonic endarterectomy]. Angiol Sosud Khir (2007) 0.75

[Heart rhythm disturbances in patients with chronic obstructive pulmonary disease in aggregate with coronary heart disease]. Klin Med (Mosk) (2008) 0.75

[The differential use of fibrinolysis activators and inhibitors in treating acute abscesses and gangrene of the lungs]. Grudn Khir (1990) 0.75

[Surgical method in treatment of squamous cell carcinoma of the mouth cavity and oral part of the pharynx]. Vestn Khir Im I I Grek (2007) 0.75

[Biochemical mechanisms of the role of neutrophils in reactions of acute inflammation (review of the literature)]. Vopr Med Khim (1989) 0.75

[Ultrasonic cavitation and laser therapy in acute suppurative diseases of soft tissues and glandular organs]. Khirurgiia (Mosk) (1988) 0.75

[Digestive system pathology in patients with chronic obstructive pulmonary disease concurrent with coronary heart disease]. Ter Arkh (2010) 0.75

[Means of improvement of surgical treatment for oropharyngeal planocellular carcinoma]. Vopr Onkol (2007) 0.75

[Changes in central hemodynamics and the effect of transfusion therapy during surgical treatment of patients with mechanical jaundice]. Anesteziol Reanimatol (1987) 0.75

[Surgical treatment of extensive hemangiomas of the liver]. Khirurgiia (Mosk) (1991) 0.75

[A method to eliminate lipids from blood plasma in hyperlipidemias to measure activities of proteinases and their inhibitors]. Klin Lab Diagn (1996) 0.75

[Restoration of the microcirculation in the treatment of acute destructive lung diseases]. Klin Med (Mosk) (1988) 0.75

[Identity of human granulocyte kininogenase and plasminogen activator]. Ukr Biokhim Zh (1978) (1983) 0.75

[Variants of procedures of artificial blood circulation and the proteinase activity of the blood]. Anesteziol Reanimatol (1990) 0.75

[The treatment of posttraumatic hemothorax]. Grud Serdechnososudistaia Khir (1993) 0.75

[Computed tomography and study of external respiratory function in the diagnosis of complications due to chronic obstructive lung disease]. Klin Med (Mosk) (2004) 0.75

[Inhibition of human granulocyte elastase by antibodies to leukocyte thermostable alpha-glycoprotein]. Biull Eksp Biol Med (1988) 0.75

[A new method of isolating acid-stable trypsin inhibitor from human urine]. Biokhimiia (1993) 0.75

[Clinical characteristics of various histological forms of lung cancer]. Vopr Onkol (1975) 0.75

[Cryoplasmic-antienzyme therapy in infectious destructive diseases of the lungs]. Ter Arkh (1987) 0.75

[Complex treatment of infectious destructive lung diseases using frozen plasma and enzyme inhibitors]. Grudn Khir (1986) 0.75

[Correction of cellular and humoral defense reactions in the surgical treatment of acute cholecystitis]. Khirurgiia (Mosk) (1991) 0.75

[Microcirculation in patients with lung cancer]. Vopr Onkol (1977) 0.75

[Comparative evaluation of the health status of descendants of people residing in environmentally unfriendly regions by means of mathematical modeling]. Klin Med (Mosk) (2014) 0.75

["Premature mortality" as an integral indicator of the quality of medical care]. Sov Zdravookhr (1990) 0.75

[Use of thermo- and acid-stable proteinase inhibitor to suppress proteolytic activation in pulmonary inflammation]. Biull Eksp Biol Med (1992) 0.75

[Acid-stable protein proteinase inhibitors of mammals. Structure, properties, biological role]. Biokhimiia (1982) 0.75

[Amino acid sequence in the reactive site region of an acid-stable inhibitor of trypsin, chymotrypsin and intracellular proteinases from rabbit serum]. Bioorg Khim (1983) 0.75

[The distinctive characteristics of malignant neoplasms in the population of the Altai Territory subjected to long-term radiation exposure as a consequence of the multiyear nuclear explosives tests at the Semipalatinsk proving ground]. Vopr Onkol (1995) 0.75

[Computed tomographic findings in patients with chronic pulmonary obstruction and diabetes mellitus]. Klin Med (Mosk) (2011) 0.75

[Treatment of the acute lung abscess without sequestration]. Khirurgiia (Mosk) (2012) 0.75

[Surgical treatment of malignant tumors in the biliopancreatoduodenal zone]. Khirurgiia (Mosk) (2002) 0.75

[Inhibition of kininogenase activity of cathepsins D by acid-resistant proteinase inhibitor from rabbit serum]. Biokhimiia (1981) 0.75

[Seasonal cyclicity of acute arterial ischaemia and acute ascending varicothrombophlebitis]. Angiol Sosud Khir (2013) 0.75

[Local permanent intraarterial antimicrobic therapy in postoperative period at the patients with cholangitis]. Khirurgiia (Mosk) (2008) 0.75

[Disorders of the central hemodynamics and the volume of circulating blood and its components during the surgical treatment of destructive cholecystitis]. Anesteziol Reanimatol (1986) 0.75

[The prognosis of the course of pleural empyema and pyopneumothorax]. Ter Arkh (1993) 0.75

[Treatment of acute abscesses and gangrene of the lungs]. Grud Serdechnososudistaia Khir (1991) 0.75

[Value of correcting microcirculatory disorders of inflammatory foci in the treatment of infection]. Khirurgiia (Mosk) (1989) 0.75

[Pathomorphology of radiation-induced changes in the bronchi at a distant period after exposure]. Biull Eksp Biol Med (1995) 0.75

[Imbalance in the proteinase-inhibitor system in obstetric sepsis and septic shock]. Klin Lab Diagn (2003) 0.75

[Hemodynamics of the lesser circulation in lung cancer]. Vopr Onkol (1980) 0.75